ConductScience.org, home

Trial · NCT05280873

Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP

NCT05280873, Phase 1, Unknown, Zhou Chengzhi

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP. Trials, record NCT05280873. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05280873

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP
NCT number
NCT05280873
Status
Unknown
Phases
Phase 1
Enrollment
48 participants, estimated
Lead sponsor
Zhou Chengzhi
Conditions
Pneumonitis, Malignant Tumor
Interventions
Pirfenidone, methylprednisolone, Methylprednisolone
First posted
2022-03-15
Last updated
2022-03-15

Source ClinicalTrials.gov

Registered outcomes5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryDegradation time of CIPApproximately 3 monthsAccording to CTCAE 4.0 and imaging grade of CIP, the time of reduction by one grade was evaluated.
PrimaryProportion of degradation within three monthsApproximately 3 monthsThe number of enrollments reduced by grade 1 in 3 months divided by the total number of enrollments.
SecondarySafety(Adverse Events)From the day the patient signs informed consent form until 30 days after the last medicationSafety will be assessed according to common terminology criteria for adverse events version 4.0 (CTCAE 4.0)
SecondaryTotal amount of hormoneFrom the day the patient signs informed consent to the last medication,assessed up to 24 monthsTotal amount of methylprednisolone
SecondaryMMRC scoreFrom the day the patient received treatment until 30 days after the last medicationChange of Modified Medical Research Council Dyspnea Scale

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT05280873

GET https://conductscience.org/api/trials/v1/NCT05280873/registered